AbbVie Executive and Leadership Team

Jennifer Davis, the Chief Executive Officer, Health Care at AbbVie, provides overarching leadership and strategic direction for the companys healthcare business segment. This executive role involves setting the vision and driving the execution of strategies aimed at improving patient outcomes and expanding access to innovative health solutions. Davis oversees the performance of key business units within the healthcare sector, ensuring alignment with AbbVie's core mission. The Chief Executive Officer's responsibilities include fostering a culture of innovation, guiding product development, and managing relationships with key stakeholders, including healthcare providers and regulatory bodies. Jennifer Davis is instrumental in navigating the complex healthcare landscape, championing the companys commitment to addressing significant unmet medical needs. This leadership position is critical for advancing AbbVie's impact on global health and ensuring the delivery of transformative therapies that enhance the quality of life for patients across diverse therapeutic areas.

Scott Reents, the Executive VP & Chief Financial Officer at AbbVie, directs all financial operations and strategic financial planning for the global biopharmaceutical enterprise. This executive leadership role encompasses managing the companys fiscal health, capital allocation, and investor relations. Reents oversees budgeting, forecasting, and financial reporting, ensuring compliance and driving financial performance across all business units. The Chief Financial Officer's responsibilities extend to evaluating investment opportunities, managing risk, and optimizing the companys capital structure to support long-term growth and innovation. Scott Reents plays a pivotal part in shaping AbbVie's financial strategy, aligning fiscal decisions with the companys mission to deliver groundbreaking medicines. This executive's guidance is essential for sustaining the companys robust research and development pipeline and its commitment to addressing complex medical challenges worldwide, thereby ensuring financial stability and enabling the pursuit of new therapeutic breakthroughs.

Pinar Ceylan, the Director, Finance & Chief Financial Officer at AbbVie, manages critical financial functions and contributes to the companys fiscal strategy, particularly within specific financial domains. This role involves overseeing financial planning, analysis, and reporting to support operational efficiency and strategic decision-making. Ceylan ensures the integrity of financial data and compliance with regulatory requirements, safeguarding the companys financial health. The Chief Financial Officer's responsibilities include supporting budget management and resource allocation to drive AbbVie's research and development initiatives. Pinar Ceylan's expertise is vital in navigating the financial complexities of the biopharmaceutical industry, enabling the company to pursue its mission of developing innovative medicines. This executive's contributions are essential for maintaining financial discipline and supporting the strategic growth of AbbVie's therapeutic areas, ultimately impacting the delivery of life-changing treatments to patients globally.

Hasan Kurt, the Chief Financial Officer, Integration Lead Allergan Aesthetics at AbbVie, directs financial operations and spearheads the integration of Allergan Aesthetics into AbbVie's financial framework. This executive role involves managing the financial aspects of the integration process, ensuring seamless transition and operational synergy. Kurt oversees financial planning, reporting, and compliance for the Allergan Aesthetics business, aligning its financial performance with AbbVie's broader objectives. The Chief Financial Officer's responsibilities include optimizing financial structures and driving cost efficiencies to support growth in the medical aesthetics sector. Hasan Kurt's expertise is vital for realizing the full value of the Allergan Aesthetics acquisition, enhancing AbbVie's position in the market. This leadership function is critical for integrating new business units effectively and ensuring sustained financial health and strategic advancement across all of AbbVie's diverse therapeutic areas.

Jeanne Martinez, the Regional Chief Financial Officer at AbbVie, oversees financial operations and strategic financial planning for a specific geographic region. This executive role involves managing regional budgets, forecasting financial performance, and ensuring fiscal compliance within the designated territory. Martinez plays a key part in optimizing resource allocation and driving financial efficiency across regional business units. The Chief Financial Officer's responsibilities include providing financial insights to support regional growth strategies and market expansion initiatives. Jeanne Martinez's financial acumen is essential for navigating regional market dynamics and contributing to AbbVie's overall financial stability and success. This leadership position directly supports the companys global mission by ensuring sound financial management at a regional level, enabling the effective delivery of innovative medicines to patients.

Carrianne Ludwig, the Director of Chief Revenue Officer and Vendor Partnerships, Oncology Early Development at AbbVie, drives revenue generation and strategic vendor relationships within the oncology early development sector. This leadership position involves cultivating key partnerships that accelerate the advancement of novel cancer therapies. Ludwig's focus centers on optimizing commercial strategies and ensuring robust vendor support for critical research initiatives. The role demands a deep understanding of the biopharmaceutical market and the specific needs of early-stage oncology drug development. By managing these vital external relationships, Ludwig directly contributes to AbbVie's mission of bringing life-changing treatments to patients facing serious diseases. The strategic alignment of vendor capabilities with research timelines is paramount to achieving development milestones and expanding market access for innovative oncology solutions. This executive ensures that the financial and operational aspects of vendor collaborations are meticulously managed to support the companys overarching goals in combating cancer.

Sarah Kopecky-Bromberg, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff at AbbVie, orchestrates strategic initiatives across development and operations, functioning as a key advisor within specialty areas. This role involves translating high-level corporate objectives into actionable plans for critical operational segments. Kopecky-Bromberg ensures seamless integration between strategic planning and day-to-day execution, particularly within specialized therapeutic domains. The position requires a comprehensive grasp of AbbVie's operational landscape and the ability to drive cross-functional alignment. By providing strategic direction and operational oversight, Sarah Kopecky-Bromberg supports the efficient progression of drug development programs and the effective deployment of resources. This leadership function is crucial for maintaining agility and responsiveness in complex research and development environments, directly impacting the timely delivery of innovative health solutions to patients worldwide. The executive's responsibilities include refining operational workflows and enhancing strategic decision-making processes across key business units.

Martin Hayes, the Global Neuroscience & Ophthalmology Research Chief of Staff at AbbVie, provides critical operational and strategic support for research initiatives in neuroscience and ophthalmology. This role involves coordinating efforts across global research teams to accelerate the discovery and development of novel treatments for neurological and eye-related conditions. Hayes ensures alignment between research objectives and operational execution, facilitating seamless progress in these complex therapeutic areas. The Chief of Staff's responsibilities include managing key projects, optimizing research workflows, and fostering collaboration among scientists and cross-functional teams. Martin Hayes's leadership is essential for advancing AbbVie's pipeline of innovative therapies, addressing significant unmet medical needs in neuroscience and ophthalmology. This executive's focus on operational excellence directly supports the companys commitment to improving patient outcomes and enhancing the quality of life for individuals affected by debilitating diseases.

Jenina Nunez, the Chief of Staff, Intercontinental at AbbVie, drives strategic initiatives and operational alignment across the companys intercontinental markets. This executive role focuses on enhancing AbbVie's global presence and ensuring the effective execution of business strategies in diverse international regions. Nunez coordinates cross-functional efforts to support market access, product launches, and business development activities outside of North America. The Chief of Staff's responsibilities include facilitating communication between regional leadership and corporate headquarters, ensuring cohesive strategic implementation. Jenina Nunez's leadership is crucial for navigating the complexities of global pharmaceutical markets and advancing AbbVie's mission to deliver innovative medicines worldwide. This executive's work directly contributes to expanding patient access to life-changing therapies and reinforcing AbbVie's commitment to addressing critical health challenges on a global scale.

Linda Ray, the Senior VP & Chief Information Officer at AbbVie, directs the companys global information technology strategy and operations, ensuring robust digital infrastructure to support business objectives. This executive leadership role encompasses overseeing all aspects of IT, including cybersecurity, data management, and technology innovation. Ray is responsible for implementing advanced technological solutions that enhance operational efficiency, drive research and development, and improve patient engagement. The Chief Information Officer's mandate includes safeguarding sensitive data and ensuring the reliability and scalability of IT systems across AbbVie's worldwide operations. Linda Ray's strategic vision is critical for leveraging technology to accelerate drug discovery, streamline clinical trials, and enhance the overall delivery of health solutions. This leadership position is fundamental to AbbVie's digital transformation and its commitment to using cutting-edge technology to address complex medical challenges.